Private company
CHI Advisors LLC
Limited liability company registered in the United States, active since 2002. Summary from the record
Last updated Oct 21, 2026.
Overview
Corporate structure
CHI Advisors LLC sits at the top of its group. 12 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- CHI Advisors LLC New York, New York, United States
- Corvus Pharmaceuticals, Inc. Stake · Burlingame, California, United States
- Cullinan Oncology Stake · Cambridge
- Freeline Therapeutics Holdings plc Stake · Stevenage, United Kingdom
- Inozyme Pharma, Inc. Stake · Boston, Massachusetts
- Oncorus, Inc. Stake · Andover, Massachusetts
- Orchard Therapeutics Stake · London, United Kingdom
- Pliant (United States) Stake · South San Francisco, California
- Repare Therapeutics Inc. Stake · Saint-Laurent, Canada
- VectivBio Holding AG Stake · V8
- Zafgen (United States) Stake · Boston, Massachusetts, United States
- CHI EF II LP Fund · New York, New York, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (10 companies). Each entity in the chart links to its source.
Timeline
- Dec 6, 2002Founded CHI Advisors LLC is founded2
Filings
10 filings to the SEC since October 2021: 10 other. The latest 10:
- Nov 13, 202313F-HR EDGAR
- Aug 22, 202313F-HR/A EDGAR
- Aug 11, 202313F-HR EDGAR
- May 11, 202313F-HR EDGAR
- Feb 13, 202313F-HR EDGAR
- Nov 9, 202213F-HR EDGAR
- Aug 12, 202213F-HR EDGAR
- May 16, 202213F-HR EDGAR
- Feb 11, 202213F-HR EDGAR
- Nov 15, 202113F-HR EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
CHI Advisors LLC has told the SEC it owns more than 5% of 10 companies, latest first (Schedules 13D and 13G).
- Corvus Pharmaceuticals, Inc.SC 13G Feb 13, 20233
- Cullinan OncologySC 13G/A Feb 11, 2022 to Feb 13, 20234
- Freeline Therapeutics Holdings plcSC 13G/A Feb 11, 2022 to Feb 13, 20235
- Inozyme Pharma, Inc.SC 13G Feb 13, 20236
- Oncorus, Inc.SC 13G/A Feb 11, 2022 to Feb 13, 20237
- Orchard TherapeuticsSC 13G/A Feb 11, 2022 to Feb 13, 20238
- Pliant (United States)SC 13G/A Feb 11, 2022 to Feb 13, 20239
- Repare Therapeutics Inc.SC 13G/A Feb 11, 2022 to Feb 13, 202310
- VectivBio Holding AGSC 13G/A Feb 11, 2022 to Feb 13, 202311
- Zafgen (United States)SC 13G/A Feb 11, 2022 to Feb 13, 202312
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12